BackSino Biopharmaceutical Overview

Sino Biopharmaceutical Goodwill

Latest goodwill for SBHMY: $3.5B.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$3.50B
281.81% YoYΔ $2.58B vs prior year quarter

Peer trimmed avg / median

Loading

Sino Biopharmaceutical Goodwill History

Loading

Sino Biopharmaceutical vs. peers: Goodwill Comparison

Loading

Sino Biopharmaceutical Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sino Biopharmaceutical (SBHMY) FAQ

As of the most recent data (December 2025), SBHMY shows a goodwill of $3.5B. That compares with $920M in the prior-year period — up 281.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SBHMY's goodwill is now $3.5B (was $920M) — a 281.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Sino Biopharmaceutical is outperforming or lagging.

Tracking SBHMY's goodwill over time shows whether Sino Biopharmaceutical is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5B That compares with $920M in the prior-year period — up 281.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Sino Biopharmaceutical's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $3.5B) with ownership activity and broader fundamentals.

Sino Biopharmaceutical's goodwill is $3.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.